Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 315

The DOI matches its Crossref record; 282 of the 282 references it cites were found in a registry or an index.

Immune and inflammatory mechanisms in hypertension

Open access
Guzik, Tomasz J., Nosalski, Ryszard, Maffia, Pasquale, Drummond, Grant R.·2024·Nature Reviews Cardiology

Abstract

Hypertension is a global health problem, with >1.3 billion individuals with high blood pressure worldwide. In this Review, we present an inflammatory paradigm for hypertension, emphasizing the crucial roles of immune cells, cytokines and chemokines in disease initiation and progression. T cells, monocytes, macrophages, dendritic cells, B cells and natural killer cells are all implicated in hypertension. Neoantigens, the NLRP3 inflammasome and increased sympathetic outflow, as well as cytokines (including IL-6, IL-7, IL-15, IL-18 and IL-21) and a high-salt environment, can contribute to immune activation in hypertension. The activated immune cells migrate to target organs such as arteries (especially the perivascular fat and adventitia), kidneys, the heart and the brain, where they release effector cytokines that elevate blood pressure and cause vascular remodelling, renal damage, cardiac hypertrophy, cognitive impairment and dementia. IL-17 secreted by CD4+ T helper 17 cells and γδ T cells, and interferon-γ and tumour necrosis factor secreted by immunosenescent CD8+ T cells, exert crucial effector roles in hypertension, whereas IL-10 and regulatory T cells are protective. Effector mediators impair nitric oxide bioavailability, leading to endothelial dysfunction and increased vascular contractility. Inflammatory effector mediators also alter renal sodium and water balance and promote renal fibrosis. These mechanisms link hypertension with obesity, autoimmunity, periodontitis and COVID-19. A comprehensive understanding of the immune and inflammatory mechanisms of hypertension is crucial for safely and effectively translating the findings to clinical practice. In this Review, Guzik and colleagues discuss immune and inflammatory mechanisms of hypertension, including upstream regulators and downstream effectors as well as the complex interplay between the immune system, blood pressure regulation and end-organ damage, which can help to identify new targets for therapeutic interventions. Hypertension is a global health challenge, affecting >1.3 billion people worldwide, and the development of this condition is closely associated with inflammatory dysregulation and immune activation. Immune cells such as CD8+ T cells, T helper 17 cells, regulatory T cells, monocytes, macrophages and B cells, as well as chemokines and cytokines, such as IL-17, IL-18, interferon-γ and tumour necrosis factor, have crucial roles in the immune mechanisms underlying hypertension. Relevant immune mechanisms can be grouped into two clusters: those involved in the regulation of the initial immune and inflammatory activation, and the immune effector mechanisms linking the immune system to end-organ mechanisms that regulate blood pressure. Dendritic cells presenting neoantigens, NLRP3 inflammasome activity and neuroimmune activation all contribute to the immune activation process in hypertension. Activated immune cells migrate to target organs, such as the arteries (especially the perivascular fat and adventitia), kidneys and brain, causing end-organ damage and elevating the blood pressure. A deeper understanding of the immune crosstalk between the upstream regulators and downstream effectors in hypertension will enable the application of these findings effectively in clinical settings. Hypertension is a global health challenge, affecting >1.3 billion people worldwide, and the development of this condition is closely associated with inflammatory dysregulation and immune activation. Immune cells such as CD8+ T cells, T helper 17 cells, regulatory T cells, monocytes, macrophages and B cells, as well as chemokines and cytokines, such as IL-17, IL-18, interferon-γ and tumour necrosis factor, have crucial roles in the immune mechanisms underlying hypertension. Relevant immune mechanisms can be grouped into two clusters: those involved in the regulation of the initial immune and inflammatory activation, and the immune effector mechanisms linking the immune system to end-organ mechanisms that regulate blood pressure. Dendritic cells presenting neoantigens, NLRP3 inflammasome activity and neuroimmune activation all contribute to the immune activation process in hypertension. Activated immune cells migrate to target organs, such as the arteries (especially the perivascular fat and adventitia), kidneys and brain, causing end-organ damage and elevating the blood pressure. A deeper understanding of the immune crosstalk between the upstream regulators and downstream effectors in hypertension will enable the application of these findings effectively in clinical settings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41569-023-00964-1

Cites

282 of 282 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 282 references

Cited by

See all 315

Metadata

Authors
Guzik, T. J., Nosalski, R., Maffia, P., & Drummond, G. R.
Venue
Nature Reviews Cardiology
Published
2024-01-03
Volume
21
Issue
6
Pages
396-416
ISSN
  • 1759-5002 (ISSN-L)
  • 1759-5010
OpenAlex
W4390571844
Cited by
315
References
282
FWCI
16.57
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immune and inflammatory mechanisms in hypertension. https://app.cochat.ai/papers/10.1038/s41569-023-00964-1
The paper
Guzik, T. J., Nosalski, R., Maffia, P., & Drummond, G. R. (2024). Immune and inflammatory mechanisms in hypertension. Nature Reviews Cardiology. https://doi.org/10.1038/s41569-023-00964-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.